Diseases, Conditions, Syndromes

Mucosal antibodies in the airways protect against omicron infection

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many people do not receive detectable antibodies in the airways despite three doses of the SARS-CoV-2 vaccine. These are the ...

Medical research

New antiviral therapy may block COVID-19 transmission

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system. With each breath, you expel invisible viral particles into the air—a process known as viral shedding. ...

Diseases, Conditions, Syndromes

SARS-CoV-2 protein caught severing critical immunity pathway

Over the past two years, scientists have studied the SARS-CoV-2 virus in great detail, laying the foundation for developing COVID-19 vaccines and antiviral treatments. Now, for the first time, scientists at the Department ...

Diseases, Conditions, Syndromes

Chronic COVID infections source of variants of concern, study shows

The coronavirus variants of concern are emerging from chronic, long-term COVID infections in people who may be immune comprised and unable to clear the virus, a new study strongly suggests. Frontiers in Virology published ...

Diseases, Conditions, Syndromes

Powerful new antibody neutralizes all known SARS-CoV-2 variants

As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially omicron, have developed ways to evade the antibodies we make in response ...

Diseases, Conditions, Syndromes

New test may predict COVID immunity

Most people in the United States have some degree of immune protection against COVID-19, either from vaccination, infection, or a combination of the two. But, just how much protection does any individual person have?

page 8 from 40